Literature DB >> 30567853

Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and/or autism.

Rohit Shankar1,2, Mike Wilcock3, Katy Oak3, Paula McGowan4, Rory Sheehan5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30567853     DOI： 10.1136/dtb.2018.000009

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN： 0012-6543


× No keyword cloud information.
  3 in total

Review 1.  Non-pharmacological interventions for challenging behaviours of adults with intellectual disabilities: A meta-analysis.

Authors:  E Bruinsma; B J van den Hoofdakker; A P Groenman; P J Hoekstra; G M de Kuijper; M Klaver; A A de Bildt
Journal:  J Intellect Disabil Res       Date:  2020-06-17

2.  A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study.

Authors:  Rory Sheehan; André Strydom; Louise Marston; Nicola Morant; Federico Fiori; Paramala Santosh; Angela Hassiotis
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

3.  Appropriateness of psychotropic medication use in a cohort of adolescents with intellectual disability in Queensland, Australia.

Authors:  Menghuan Song; Robert S Ware; Tan N Doan; Lyn McPherson; Julian N Trollor; David Harley
Journal:  BJPsych Open       Date:  2020-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.